2. Academic Validation
  3. Cambendazole in the treatment of human strongyloidiasis

Cambendazole in the treatment of human strongyloidiasis

  • Am J Trop Med Hyg. 1983 Sep;32(5):1181-3. doi: 10.4269/ajtmh.1983.32.1181.
S A Bicalho,  O J Leão,  Q Pena Jr
PMID: 6625071 DOI: 10.4269/ajtmh.1983.32.1181
Abstract

Cambendazole was used for the treatment of strongyloidiasis in 40 hospitalized patients, given in a single dose of 5 mg/kg body weight. According to the criteria adopted, parasitological cure was obtained in 100% of cases. Side effects were negligible, and did not require interruption of treatment. We therefore conclude that cambendazole is at present the most effective agent for the therapy of human strongyloidiasis.

Figures
Products